Takeda survey results show pharmacists believe more patient information about insomnia medications is necessary.
A national survey of 250 pharmacists in the United States found that, while 96% of respondents feel that they have sufficient education and information on the proper use of prescription insomnia medications to adequately counsel patients, more than half felt that more information should be available to them that explains the differences between the available medications. In addition, 32% of pharmacists ?completely agree? that this same information should be made available to patients as well, and three out of four pharmacists think it is extremely important to have the proper tools to effectively counsel patients on prescription insomnia medications. The survey was sponsored by Takeda Pharmaceuticals North America. Additional study information is available by contacting Amy Losak at (646) 935-3917.
To see more Daily News articles, click here.
To go to the Drug Topics homepage, click here.
Pharmacists Play Unique Role in Advancing Health Equity for Patients With Chronic Disease
December 7th 2023A new study, outlined in a poster at ASHP Midyear 2023, identified 3 key themes associated with the ways in which pharmacists are positioned to advance health equity for patients with chronic diseases.
Assessing Financial Impacts of Pharmacist-Led Interventions in Pediatric Ambulatory Care
December 5th 2023According to a poster abstract presented at the ASHP Midyear Clinical Meeting & Exhibition, specialty pharmacy services were used for a variety of conditions that have been reported in adult populations.